China Money Network
Login
Join

Chinese Clinical-Stage Innovative Drug Developer Kangpu Raises Nearly $14M

  • August 9, 2019 — 14:47 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese clinical-stage innovative drug developer Kangpu Biopharmaceuticals unveiled on Friday that it has raised nearly RMB100 million (US$14.18 million) in a series pre-B round of... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: